About this trial
Serum ferritin is a key indicator of body iron stores and is widely used in monitoring iron status. However, oral iron doses can acutely elevate SF levels, potentially biasing assessments of iron stores during supplementation. This study aims to investigate the extent and duration of the acute iron-induced effect on serum ferritin following the administration of a daily iron dose for two months.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Low iron stores (SF levels < 30 µg/L),
no anemia (Hb > 120 g/L)
no inflammation (CRP < 5 mg/L)
18 to 45 years old.
Disqualifiers
Any chronic or acute disease
Consumption of mineral and vitamin supplements since screening and over the study period
Blood transfusion, blood donation or significant blood loss over the past 4 months,
Pregnant or breastfeeding,
Trial design
Parallel
Treatments tested in this trial
ferrous sulfate 80 mg
Dietary supplement1 tablet per day
ferrous sulfate 160 mg
Dietary supplement2 tablets per day
Treatment groups
Trial outcomes
Primary outcomes
Serum ferritin
Serum ferritin concentration
Serum ferritin
Serum ferritin concentration
Serum ferritin
Serum ferritin concentration
Serum ferritin
Serum ferritin concentration
Secondary outcomes
alpha(1)-acid-glycoprotein
alpha(1)-acid-glycoprotein concentration in serum
Serum ferritin
Serum ferritin concentration
Serum ferritin
Serum ferritin concentration
Serum ferritin
Serum ferritin concentration
Sponsors and contacts
Click on the lead sponsor to view all of their trials.